Human-Relevant Models Come of Age
April 6, 2026
Why vascularized tissues are gaining traction
7 min read
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
April 6, 2026
Engineered immune cells clear amyloid and improve brain health in mice, offering a new direction for neurodegenerative therapy
1 min read
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
April 1, 2026
A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy
1 min read
March 31, 2026
New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration
1 min read
March 30, 2026
From capital scarcity to clinical impact, execution and partnerships are redefining the industry’s next chapter.
5 min read
March 30, 2026
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
1 min read
March 30, 2026
In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing
1 min read
False